OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ocrelizumab Concentration Is a Good Predictor of SARS‐CoV ‐2 Vaccination Response in Patients with Multiple Sclerosis
Zoé L.E. van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Annals of Neurology (2022) Vol. 93, Iss. 1, pp. 103-108
Open Access | Times Cited: 12
Zoé L.E. van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Annals of Neurology (2022) Vol. 93, Iss. 1, pp. 103-108
Open Access | Times Cited: 12
Showing 12 citing articles:
Extended interval dosing with ocrelizumab in multiple sclerosis
Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 7, pp. 847-856
Closed Access | Times Cited: 5
Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 7, pp. 847-856
Closed Access | Times Cited: 5
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
Jim Keijser, Eileen W Stalman, Luuk Wieske, et al.
EBioMedicine (2025) Vol. 113, pp. 105620-105620
Closed Access
Jim Keijser, Eileen W Stalman, Luuk Wieske, et al.
EBioMedicine (2025) Vol. 113, pp. 105620-105620
Closed Access
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
Niels J. M. Verstegen, Ruth R Hagen, Christine Kreher, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 9, pp. 855-864
Open Access | Times Cited: 3
Niels J. M. Verstegen, Ruth R Hagen, Christine Kreher, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 9, pp. 855-864
Open Access | Times Cited: 3
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis
Alyssa A Toorop, Laura Hogenboom, Karien Bloem, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 6, pp. 487-493
Closed Access | Times Cited: 8
Alyssa A Toorop, Laura Hogenboom, Karien Bloem, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 6, pp. 487-493
Closed Access | Times Cited: 8
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma
Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 684-684
Open Access | Times Cited: 2
Georges Katoul Al Rahbani, Christina Woopen, Marie Dunsche, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 684-684
Open Access | Times Cited: 2
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 3, pp. 754-766.e7
Open Access
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 3, pp. 754-766.e7
Open Access
A Liquid Chromatography - Tandem Mass Spectrometry Method for Determination of Ocrelizumab in Serum of Patients with Multiple Sclerosis
Patrik Matlak, Hana Brozmanová, Pavel Šištík, et al.
(2024)
Closed Access
Patrik Matlak, Hana Brozmanová, Pavel Šištík, et al.
(2024)
Closed Access
Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients—a longitudinal cohort study
Frederik Novak, Anna Christine Nilsson, Emil Birch Christensen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Frederik Novak, Anna Christine Nilsson, Emil Birch Christensen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A liquid chromatography - tandem mass spectrometry method for determination of ocrelizumab in serum of patients with multiple sclerosis
Patrik Matlak, Hana Brozmanová, Pavel Šištík, et al.
Talanta (2024) Vol. 283, pp. 127111-127111
Closed Access
Patrik Matlak, Hana Brozmanová, Pavel Šištík, et al.
Talanta (2024) Vol. 283, pp. 127111-127111
Closed Access
Longitudinal Dynamics of the SARS-CoV-2 Antibody Repertoire after SARS-CoV-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
(2023)
Closed Access
Eileen W Stalman, Luuk Wieske, Jim Keijser, et al.
(2023)
Closed Access
